全球血液製品市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球血液製品市場預計將從2025年的586.2億美元成長至2034年的998.8億美元，2026年至2034年的複合年成長率（CAGR）為6.1%。這個市場穩定成長的原因在於外科手術、創傷治療、癌症治療和慢性病管理等領域對血液成分的需求不斷增加。血液疾病盛行率的上升以及人們對捐血計畫認知的提高也推動了市場擴張。醫療機構正在投資先進的血液處理技術，以提高血液儲存、分離和輸注的效率。此外，自動化血液製品系統的日益普及也提高了檢查室的生產效率並最大限度地降低了污染風險。

離心分離系統、血液分析儀和病原體去除技術的進步顯著改善了血液製品的生產流程。醫院和血庫正致力於更安全的輸血操作和更有效率的庫存管理，以滿足日益成長的醫療保健需求。政府鼓勵自願捐血和加強醫療基礎設施建設的措施也促進了市場發展。全球人口老化和外科手術量的增加，使得血液製品和服務的需求持續成長。

未來成長機會預計將來自自動化、數位追蹤系統和先進的血漿分離技術。新興市場對醫療基礎設施投資的增加，可望促進血液製品設備的更廣泛應用。專注於人工血液替代品和改良型儲存技術的研究，或將逐步改變產業格局。醫療服務提供者與科技公司之間的策略合作，有望推動創新，並增強市場的長期成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含多個關鍵組成部分，旨在幫助您全面了解市場環境。

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這其中包含對競爭動態和主要參與企業所採用策略的寶貴見解。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，以更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在的成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球血液製品市場：依產品類型分類

• 市場分析、洞察與預測
• 全血
• 血液成分
• 血液製品

第5章 全球血液製品市場：以血液稀釋劑分類

• 市場分析、洞察與預測
• 抗凝血劑
• 線性溶劑
• 血小板凝集抑制劑

第6章 全球血液製品市場：依應用分類

• 市場分析、洞察與預測
• 血小板增多症
• 肺動脈栓塞
• 腎功能障礙
• 其他

第7章 全球血液製品市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院和外科中心
• 血液和血漿庫
• 其他

第8章 全球血液製品市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • CSL Behring
  • Takeda Pharmaceutical Company Limited
  • Baxter International Inc
  • Grifols SA
  • Octapharma AG
  • Pfizer Inc
  • Bayer AG
  • Sanofi
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Daiichi Sankyo Company Limited
  • GlaxoSmithKline Plc
  • LEO Pharma A/S
  • Abbott Laboratories
  • Haemonetics Corporation

The global blood preparation market size is expected to reach USD 99.88 Billion in 2034 from USD 58.62 Billion in 2025, growing at a CAGR of 6.1 during 2026-2034.This market is growing steadily due to increasing demand for blood components in surgeries, trauma care, cancer treatment, and chronic disease management. Rising prevalence of hematological disorders and growing awareness regarding blood donation programs are supporting market expansion. Healthcare institutions are investing in advanced blood processing technologies to improve storage, separation, and transfusion efficiency. Increasing adoption of automated blood preparation systems is also enhancing laboratory productivity and minimizing contamination risks.

Technological advancements in centrifugation systems, blood analyzers, and pathogen reduction technologies are significantly improving blood preparation procedures. Hospitals and blood banks are focusing on safer transfusion practices and efficient inventory management to meet rising healthcare demands. Government initiatives promoting voluntary blood donation and strengthening healthcare infrastructure are further contributing to market development. The growing geriatric population and increasing surgical procedures worldwide are creating sustained demand for blood preparation products and services.

Future growth opportunities are expected to emerge from automation, digital tracking systems, and advanced plasma separation technologies. Developing economies are witnessing rising investments in healthcare infrastructure, which is likely to support broader adoption of blood preparation equipment. Research activities focusing on artificial blood substitutes and improved storage techniques may reshape the industry landscape over time. Strategic collaborations among healthcare providers and technology companies are anticipated to drive innovation and strengthen long-term market growth.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Whole Blood
• Blood Components
• Blood Derivatives

By Blood Thinning Agents

• Anticoagulants
• Fibrinolytics
• Platelet Aggregation Inhibitors

By Application

• Thrombocytosis
• Pulmonary Embolism
• Renal Impairment
• Other Applications

By End User

• Hospitals & Surgical Centers
• Blood & Plasma Banks
• Other End Users

COMPANIES PROFILED

• CSL Behring, Takeda Pharmaceutical Company Limited, Baxter International Inc., Grifols S.A., Octapharma AG, Pfizer Inc., Bayer AG, Sanofi, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, GlaxoSmithKline plc, LEO Pharma A/S, Abbott Laboratories, Haemonetics Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD PREPARATION MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Whole Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Blood Components Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Blood Derivatives Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD PREPARATION MARKET: BY BLOOD THINNING AGENTS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Blood Thinning Agents
• 5.2. Anticoagulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Fibrinolytics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Platelet Aggregation Inhibitors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD PREPARATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Thrombocytosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pulmonary Embolism Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Renal Impairment Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD PREPARATION MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Hospitals & Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Blood & Plasma Banks Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BLOOD PREPARATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Blood Thinning Agents
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Blood Thinning Agents
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Blood Thinning Agents
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Blood Thinning Agents
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Blood Thinning Agents
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BLOOD PREPARATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 CSL Behring
  • 10.2.2 Takeda Pharmaceutical Company Limited
  • 10.2.3 Baxter International Inc
  • 10.2.4 Grifols S.A
  • 10.2.5 Octapharma AG
  • 10.2.6 Pfizer Inc
  • 10.2.7 Bayer AG
  • 10.2.8 Sanofi
  • 10.2.9 Bristol-Myers Squibb Company
  • 10.2.10 Boehringer Ingelheim International GmbH
  • 10.2.11 Daiichi Sankyo Company Limited
  • 10.2.12 GlaxoSmithKline Plc
  • 10.2.13 LEO Pharma A/S
  • 10.2.14 Abbott Laboratories
  • 10.2.15 Haemonetics Corporation